Company Profile
Hangzhou Qiwei Pharmatech Co.,Ltd was founded in 2016. We focus on providing small molecule, new modalities and CDMO services for global pharmaceutical and biotech industry. We are committed to building a high-quality CRO&CDMO platform in research, development, manufacturing, and supplying of reference compounds, novel building blocks, intermediates, APIs and drug products.
Over the past few years, we have established a state-of-the-art QC/QA system aligning with ICH guidelines for pharmaceutical manufacturing. We provide our clients with high-quality products and CMC services across the entire life-cycle of drug development.